Research Centre for Reproductive Health - Solving challenges in reproductive health The University of Adelaide Australia
Latest News
Events
Study Opportunities
Contact Us
You are here: RCRH Home > Commercialisation
RCRH Home
About Us
Media Centre
Research
Study Opportunities
Commercialisation
Members
Community
Affiliates
Consultancy
Members Resources
Links
Contact Us

 

'Serving the Community and Supporting Industry'

The Research Centre for Reproductive Health focuses on research with a Clinical and Commercial Interface.

RCRH has generated the most intellectual property technology that is subject to licence or commercialisation in the Faculty of Health Sciences over the last 5 years.  Some of the Centre's most recent achievements have been negotiating 9 Consulting Contracts, 3 Industry Research Grants, 3 Industry Sponsored collaboration Research Agreements and a spin off company start up with Reproductive Health Sciences Pty Ltd.

RCRH has worked closely with Repromed and has active relationships with other clinical organisations to identify research needs and implement research findings.  Researchers also have strong links and partnerships with companies in the human and animal assisted reproduction industry to develop novel therapeutics, devices and diagnostics.

RCRH has a number of senior researchers experienced in translation of research findings into biomedical applications and employs a full time manager to facilitate intellectual property protection and commercial development.

RCRH members hold a number of patents that have helped to initiate partnerships with industry and create spin out companies.

Collaboration and Networks

Strong linkages and associations with other leading organisations in the area of developmental and reproductive health has allowed RCRH to:

  • Enhance interdisciplinary links
  • Provide viable connections between research and clinical needs
  • Provide an interface between research and commercial interests

RCRH Research Commercialisation

RCRH Member

Relevant Research

Clinical and Health Benefits

Industry
Partner 

Jeremy Thompson & Robert Gilchrist Development of bovine and human oocyte IVM media IVF Procedure Efficiency Cook Australia
Kelton Tremellen OSMI Study Effect of novel anti-oxidant on sperm function   Roche Diagnostic &  Repromed
Sarah Robertson TGF beta and Interferon Gamma 9   GroPep
Sarah Robertson Method & Medium for In Vitro Fertilisation IVF Procedure Efficiency MediCult
Sarah Robertson & Kelton Tremellen Use of TGF Beta as a Therapeutic for recurrent miscarriage Recurrent Miscarriage Therapeutic GroPep
David Kennaway Licence agreement to market Melatonin Antibodies   Buhlmann Laboratories
Claire Roberts IGF-II use in embryo culture media for ART  A media formulation to improve implantation rate, placental morphogenesis and pregnancy outcomes following IVF/ICSI MediCult
Clarie Roberts IGF-II as a therapeutic for use in women at risk of major pregnancy complications Therapeutic to enhance placental morphogenesis and prevent or minimise pregnancy complications  
Nicole Hussey Micro-Array Rapid diagnostic to measure aneuploidy for prenatal diagnosis and preimplantation genetic diagnosis Reproductive Health Sciences Pty Ltd